Pruritus associated with cholestasis. A review of pathogenesis and management.
Khandelwal
M
M
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia 19102.
Malet
P F
PF
D000728:Androgens / Q000627:therapeutic use; D000982:Antipruritics / Q000627:therapeutic use; D001647:Bile Acids and Salts / Q000378:metabolism; D002779:Cholestasis / Q000150:complications*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use; D010956:Plasmapheresis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D015742:Propofol / Q000627:therapeutic use; D011537:Pruritus / Q000209:etiology* / Q000628:therapy; D012293:Rifampin / Q000627:therapeutic use; D014467:Ultraviolet Therapy; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000728:Androgens; D000982:Antipruritics; D001647:Bile Acids and Salts; D009292:Narcotic Antagonists; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid; D012293:Rifampin; D015742:Propofol